Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Bioresour Technol ; 351: 126974, 2022 May.
Article in English | MEDLINE | ID: mdl-35276371

ABSTRACT

The preservation efficiency of mainstream (M-ANA) and sidestream anaerobic ammonium oxidation (anammox) (S-ANA) were evaluated based on their activation energy (Ea). The Ea of M-ANA cultivated under low nitrogen loads was lower than that of S-ANA, which greatly contributed to enhancing the viability of anammox during preservation at 4 °C. After preservation for 140 d, the decay rate (bAN) of M-ANA ranged from 0.0012 to 0.0013/d; the bAN of S-ANA was 0.0036-0.0041/d. The addition of hydrazine, which requires minimal energy to activate anammox metabolism, is highly beneficial for the viability of microorganisms. The low Ea of anammox contributes to efficient reactivation with rapid reactivation of heme c, and the addition of hydrazine makes the process more beneficial. Although the specific nitrogen removal rate of the M-SNA seed sludge was much lower than that of S-ANA, the rate of M-ANA became higher after 48 days of reactivation.


Subject(s)
Ammonium Compounds , Bioreactors , Anaerobic Ammonia Oxidation , Anaerobiosis , Nitrogen/metabolism , Oxidation-Reduction , Sewage
2.
J Ethnopharmacol ; 139(2): 664-7, 2012 Jan 31.
Article in English | MEDLINE | ID: mdl-22178175

ABSTRACT

ETHNOPHARMACOLOGICAL RELEVANCE: IH-901 (20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol) is a novel ginseng saponin metabolite formed by human intestinal bacteria and is known to have antitumor and antimetastatic effects. However, there has been no pharmacokinetic study of IH-901 in human beings. AIM OF THE STUDY: The aim of this study was to investigate the pharmacokinetic differences of IH-901 from fermented and non-fermented ginseng. MATERIALS AND METHODS: To investigate whether the pharmacokinetics of IH-901 differ between fermented and non-fermented ginseng, an open label, randomized, single dose, fasting, two-period, cross-over, pharmacokinetic study was conducted. A total of 24 healthy Korean male volunteers participated in this study. All subjects were allocated into two equal groups and administered 3g of fermented or non-fermented Panax ginseng. Serial blood samples for pharmacokinetic analysis were collected in the 24 h after dosing. Plasma IH-901 concentration was measured by a validated high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method. Pharmacokinetic parameters including AUC(t), C(max), and T(max) were calculated by noncompartmental models in the BA-CALC program (KFDA, 2008, 1.0.0, Korea). RESULTS: After oral administration of fermented ginseng, 5 subjects experienced diarrhea. The means of AUC(t) and C(max) were significantly different between the two groups. In the fermented ginseng group, AUC(t) was 2083.09±91.97 ng h/mL, a 15.5-fold increase over that of IH-901 from the non-fermented group (134.50±63.10 ng h/mL), and the mean C(max) was 325.00±91.97 ng/mL in the fermented ginseng group, a 27-fold higher value than that in the non-fermented group (13.88±7.24 ng/mL). T(max) was 3.29±1.00 and 12.04±4.96 h in the fermented and non-fermented group, respectively. CONCLUSIONS: The results of this study showed that the pharmacokinetic parameters of IH-901 from fermented Panax ginseng are different from those of non-fermented ginseng, from which IH-901 is formed by intestinal fermentation.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacokinetics , Asian People , Bacteria/metabolism , Fermentation , Intestines/microbiology , Panax , Plant Preparations/pharmacokinetics , Sapogenins/pharmacokinetics , Administration, Oral , Adult , Antineoplastic Agents, Phytogenic/administration & dosage , Antineoplastic Agents, Phytogenic/adverse effects , Antineoplastic Agents, Phytogenic/blood , Chromatography, High Pressure Liquid , Cross-Over Studies , Humans , Male , Middle Aged , Models, Biological , Plant Preparations/administration & dosage , Plant Preparations/adverse effects , Plant Preparations/blood , Plants, Medicinal , Reproducibility of Results , Republic of Korea/epidemiology , Sapogenins/administration & dosage , Sapogenins/adverse effects , Sapogenins/blood , Tandem Mass Spectrometry , Young Adult
3.
Stud Health Technol Inform ; 169: 754-8, 2011.
Article in English | MEDLINE | ID: mdl-21893848

ABSTRACT

The Korean Medical Association and the Health Information Review Agency have decided to re-engineer the different Korean coding systems of health interventions based on a proposed ontology framework defined in 2010 for the prospective International Classification of Health Interventions (ICHI). The authors present the interim report of the project focused on this model: 5,338 procedures of the Korean version of ICD9-CM 5,150 procedures covered by Korean health insurance and 6,619 uncovered procedure labels were processed with the participation of 8 coders and 310 medical doctors. As of 28th January 61.8% of data was processed. The ontology framework model itself was not enough to represent all the labels when the preliminary data from obstetrics and gynecology was explored. However, when modified with 7 notations, it was possible to assign each label of ICD 9 CM Volume 3 and 30 % to 57 % of specific Korean interventions to the semantic model.


Subject(s)
Documentation/methods , Forms and Records Control/standards , Practice Patterns, Physicians'/classification , Data Collection/methods , Humans , International Classification of Diseases , Internationality , Medical Records , Medical Records Systems, Computerized , Republic of Korea , Semantics
SELECTION OF CITATIONS
SEARCH DETAIL
...